neurogranin (cas 132654-77-4) in the nucleus accumbens regulates NMDA receptor tolerance and motivation for ethanol seeking
-
Add time:08/28/2019 Source:sciencedirect.com
Dysfunction of N-methyl-d-aspartate receptor (NMDAR) signaling in the nucleus accumbens (NAc) has been implicated in the pathophysiology of alcohol use disorders (AUD). neurogranin (cas 132654-77-4) (Ng), a calmodulin-binding protein, is exclusively expressed in the post-synapse, and mediates NMDAR driven synaptic plasticity by regulating the calcium-calmodulin (Ca2+-CaM) pathway. To study the functional role of Ng in AUD, we administrated behavior tests including Pavlovian instrument transfer (PIT), operant conditioning, and rotarod test using Ng null mice (Ng–/– mice). We used adeno-associated virus (AAV)-mediated Ng expression and pharmacological manipulation to validate behavioral responses in Ng–/– mice. The results from our multidisciplinary approaches demonstrated that deficit of Ng increases tolerance to NMDAR inhibition and elicit faster cue reactivity during PIT without changes in ethanol reward. Operant conditioning results demonstrated that Ng–/– mice self-administered significantly more ethanol and displayed reduced sensitivity to aversive motivation. We identified that ethanol exposure decreases mGluR5 (metabotropic glutamate receptor 5) expression in the NAc of Ng–/– mice and pharmacological inhibition of mGluR5 reverses NMDAR desensitization in Ng–/– mice. Together these findings specifically suggest that accumbal Ng plays an essential role in the counterbalance between NMDAR and mGluR5 signaling; which alters NMDAR resistance, and thereby altering aversive motivation for ethanol and may ultimately contribute to susceptibility for alcohol addiction.
We also recommend Trading Suppliers and Manufacturers of neurogranin (cas 132654-77-4). Pls Click Website Link as below: cas 132654-77-4 suppliers
Prev:Research Reportneurogranin (cas 132654-77-4) binds α-synuclein in the human superior temporal cortex and interaction is decreased in Parkinson’s disease
Next:Rapid communicationAttenuation of opioid tolerance by antisense oligodeoxynucleotides targeting neurogranin (cas 132654-77-4)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research Reportneurogranin (cas 132654-77-4) in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease08/31/2019
- LPS-induced cortical kynurenic acid and neurogranin (cas 132654-77-4)-NFAT signaling is associated with deficits in stimulus processing during Pavlovian conditioning08/30/2019
- Rapid communicationAttenuation of opioid tolerance by antisense oligodeoxynucleotides targeting neurogranin (cas 132654-77-4)08/29/2019
- Research Reportneurogranin (cas 132654-77-4) binds α-synuclein in the human superior temporal cortex and interaction is decreased in Parkinson’s disease08/27/2019
- Serum neurogranin (cas 132654-77-4) measurement as a biomarker of acute traumatic brain injury08/26/2019
- Featured ArticleC-terminal neurogranin (cas 132654-77-4) is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease08/25/2019
- Effects of myeloid sirtuin 1 deficiency on hypothalamic neurogranin (cas 132654-77-4) in mice fed a high-fat diet08/24/2019
- neurogranin (cas 132654-77-4) regulates sensorimotor gating through cortico-striatal circuitry08/23/2019


